Prognostic Value of Steroid Receptors in Breast Cancer
Author Information
Author(s): MF Pichon, P Broet, H Magdelenat, JC Delarue, F Spyratos, JP Basuyau, S Saez, A Rallet, P Courriere, R Millon, B Asselain
Primary Institution: Groupe de Biopathologie Tissulaire et Moleculaire, Federation des Centres de Lutte contre le Cancer
Hypothesis
The expression of oestrogen and progesterone receptors in primary breast tumors is related to patient outcomes.
Conclusion
Steroid receptor status has limited prognostic value compared to established criteria in early breast cancer.
Supporting Evidence
- 68.8% of tumors were ER positive and 54.0% were PR positive.
- Significant differences in overall survival were observed based on receptor status.
- ER status lost its significance after 8 years of follow-up.
Takeaway
This study looked at how certain hormone receptors in breast cancer can help predict how well patients will do, but found that they aren't as helpful as other factors.
Methodology
A multicentric study followed 2257 operable breast cancer patients for a median of 8.5 years, measuring steroid receptor status and correlating it with clinical outcomes.
Potential Biases
Variability in patient demographics and treatment across different centers may introduce bias.
Limitations
The study relied on early steroid receptor assays, which may have selection bias due to technical requirements.
Participant Demographics
Mean age was 59 years, with 65% post-menopausal and 3.3% under 35 years.
Statistical Information
P-Value
p<0.01
Statistical Significance
p<0.001
Want to read the original?
Access the complete publication on the publisher's website